37 startups found with PMF
The AI-powered drug discovery category focuses on leveraging machine learning and computational biology to accelerate the identification and development of new therapeutics. By analyzing historical startups that achieved product-market fit in this space, founders can identify proven business models and data moats ready for modern AI integration. This sector bridges the gap between traditional biotechnology and advanced algorithmic research to reduce R&D costs and timelines.
RNA-based AI for better drugs and smarter clinical trials.
The AI-Native Operating System for Protein Engineering
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Generative AI for protein design
AI for drug formulation
AI-designed Protein Therapeutics
The dynamic single-cell analysis company
